Yuyu Pharma (000220) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma (000220) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000220 cash flow conversion to assess how effectively this company generates cash.

Yuyu Pharma - Total Liabilities Trend (2011–2024)

This chart illustrates how Yuyu Pharma's total liabilities have evolved over time, based on quarterly financial data. Check Yuyu Pharma liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Yuyu Pharma Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
CZR Resources Ltd AU:CZR	Australia	AU$5.63 Million
Rapala VMC Oyj HE:RAP1V	Finland	€136.60 Million
Bo Lak KO:002760	Korea	₩10.77 Billion
Charnic Capital Tbk PT JK:NICK	Indonesia	Rp2.91 Billion
NexLiving Communities Inc V:NXLV	Canada	CA$322.62 Million
Boreo Oyj HE:BOREO	Finland	€104.30 Million
Plutus Financial Group Limited Ordinary Shares NASDAQ:PLUT	USA	$16.23 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Yuyu Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuyu Pharma stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma (2011–2024)

The table below shows the annual total liabilities of Yuyu Pharma from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	+24.69%
2013-12-31	₩23.99 Billion ≈ $16.26 Million	+25.08%
2012-12-31	₩19.18 Billion ≈ $13.00 Million	-9.87%
2011-12-31	₩21.28 Billion ≈ $14.42 Million	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$46.55 Million

₩68.70 Billion KRW

Market Cap Rank

#22149 Global

#1482 in Korea

Share Price

₩4245.00

Change (1 day)

-1.05%

52-Week Range

₩4055.00 - ₩4770.00

All Time High

₩16106.03